<DOC>
	<DOCNO>NCT00089635</DOCNO>
	<brief_summary>The purpose study determine ABX-EGF ( panitumumab ) clinically meaningful anti-tumor activity patient metastatic colorectal cancer develop progressive disease relapse prior fluoropyrimidine , irinotecan oxaliplatin chemotherapy .</brief_summary>
	<brief_title>ABX-EGF ( Panitumumab ) Monotherapy Subjects With Metastatic Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Pathologic diagnosis colorectal adenocarcinoma ( diagnostic tissue obtain tissue biopsy ) Metastatic colorectal carcinoma Eastern Cooperative Oncology Group 0 , 1 2 Documented evidence disease progression , follow treatment , fluoropyrimidine , irinotecan oxaliplatin chemotherapy metastatic colorectal cancer Radiographic documentation disease progression within 6 month follow recent chemotherapy regimen require Bidimensionally measurable disease Tumor express low negative level EGFr immunohistochemistry At least 2 3 prior chemotherapy regimens metastatic colorectal cancer Adequate hematologic , renal hepatic function Symptomatic brain metastasis require treatment Patient history interstitial pneumonitis pulmonary fibrosis evidence interstitial pneumonitis pulmonary fibrosis Use systemic chemotherapy radiotherapy within 30 day enrollment Prior antiEGFr antibody therapy exception small molecule EGFr tyrosine kinase inhibitor , permit Prior antitumor therapy include prior experimental agent approve antitumor small molecule biologics short ( less 1 week ) serum halflife within 30 day enrollment , prior experimental approve protein within 6 week enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Colon , Rectal Cancer</keyword>
	<keyword>ABX-EGF , Panitumumab , EGFr</keyword>
	<keyword>Immunex , Abgenix , Amgen</keyword>
	<keyword>Metastatic Colorectal Cancer</keyword>
	<keyword>Vectibix</keyword>
</DOC>